Number of Shares
587.00
Current Holdings Value*
$182,880.00
% of Portfolio
4.85%
Total Estimate Gain
$-7,042.71
% of Total Estimate Gain
-3.11%

Amplify Weight Loss Drug & Treatment ETF's Amgen Inc Holding Summary

As of 2025-03-31, Amplify Weight Loss Drug & Treatment ETF held 587.00 shares of Amgen Inc(AMGN), totaling $182,880.00. This investment constitutes 4.85% of their stock portfolio, and Amplify Weight Loss Drug & Treatment ETF now holds 0% of the outstanding Amgen Inc(AMGN) stock.

The initial trade took place in 2024Q2. And since then Amplify Weight Loss Drug & Treatment ETF has made 2 purchases of AMGN, at an average price of $302.88, for a total of 747.00 shares. In addition, there have been 1 sales at an average price of $295.30 for 160.00 shares. Based on historical transaction data and AMGN's current price of $292.95, Amplify Weight Loss Drug & Treatment ETF's estimated gain on his AMGN holdings is $-7,042.71, reflecting a -3.11% gain to date.

Amplify Weight Loss Drug & Treatment ETF AMGN ($292.95) Holding Chart

Amplify Weight Loss Drug & Treatment ETF AMGN ($292.95) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1